After Integral Ad Science (IAS) agreed to be acquired by private equity firm Novacap for $10.30 per share in cash, Barclays called acquisition “a positive for the story,” noting that shares have struggled to see traction since the IPO despite IAS being “a competitive player in the AdTech market.” The firm has an Equal Weight rating and $10 price target on IAS shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IAS:
- Integral Ad Science downgraded to Hold from Buy at Craig-Hallum
- Integral Ad Science to be acquired by Novacap for $1.9B in cash
- Integral Ad Science to be acquired by Novacap for $10.30 per share, or $1.9B
- IAS Earnings Call: Strong Growth and Strategic Moves
- Integral Ad Science price target lowered to $11 from $13 at Raymond James